SCHEDULE 14A
(RULE 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ¨
Filed by a Party other than the Registrant ý
Check the appropriate box:
| ¨ | Preliminary Proxy Statement | |
| ¨ | Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| ¨ | Definitive Proxy Statement | |
| ¨ | Definitive Additional Materials | |
| ý | Soliciting Material Pursuant to §240.14a-12 | |
CRYO-CELL INTERNATIONAL, INC.
(Name of Registrant as Specified in Its Charter)
Ki Yong Choi
Michael D. Coffee
Warren Hoeffler
Michael W. Cho
Gary Weinhouse
Ajay Badlani
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
ý No fee required.
¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
| 1. | Title of each class of securities to which transaction applies: |
| 2. | Aggregate number of securities to which transaction applies: |
| 3. | Per unit price or other underlying value of transaction computed pursuant to Exchange Act |
Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| 4. | Proposed maximum aggregate value of transaction: |
| 5. | Total fee paid: |
¨ Fee paid previously with preliminary materials:
¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
| 1. | Amount previously paid: |
| 2. | Form, Schedule or Registration Statement No.: |
| 3. | Filing Party: |
| 4. | Date Filed: |
Ki Yong Choi Demands Release Of Cryo-Cell's Financial Results For The Quarter Ended May 31, 2012 Prior To The Annual Meeting
SAN FRANCISCO, July 6, 2012 /PRNewswire/ --Ki Yong Choi, who owns approximately 19.6% of the outstanding shares of Cryo-Cell International, Inc. (OTCBB: CCEL), today issued the following letter to stockholders of Cryo-Cell.
Dear Fellow Cryo-Cell Stockholder:
On July 5, 2012 Cryo-Cell International, Inc. issued a press release which included the following quote by Mr. George Gaines, chairman of the company's Compensation Committee, "David and Mark Portnoy know exactly what it takes to reverse the company's downward trend in revenue. Their plan is already showing positive results."
As the largest stockholder, I want to know what these "positive results" consist of. I believe that management should share the company's financial results for the quarter ended May 31, 2012 with the company's stockholders prior to the annual meeting; these results include, but are not limited to, revenues, cost of revenues, operating expenses with sales and marketing broken out, net income or net loss, cash and securities balance, and uses of cash. Stockholders should have this information in order to make an informed decision when voting and to determine for themselves whether the company is truly "showing positive results".
We thank you and look forward to your support.
Ki Yong Choi
Investor Contact:
Alliance Advisors LLC.
Call Toll Free: (877) 777-2338;
Banks and Brokers Call Collect: (973) 873-7700.